To evaluate the efficacy of Sariva malahara in Ahiputana in children,A Randomized controlled clinical trial

“A RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF SARIVA MALAHARA IN AHIPUTANA IN CHILDREN ? - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072709

Enrollment

Registered

2024-08-19

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children with 2 or more symptoms among the diagnosing criteria will be selected for the study. 2.Children in between the age group 3rd week to till 2 years, irrespective of gender, religion, socioeconomic status. 3.H/o of symptoms of Ahiputana / Napkin rash not more than 10 days.

Exclusion criteria

Exclusion criteria: 1.Children suffering from any other systemic disorders e.g, Acute gastro enteritis with dehydration, helminthic infection, lactogen intolerance, secondary infection etc. 2.Children who have other generalized skin infections other than Ahiputana.

Design outcomes

Primary

Measure	Time frame
assessment will be done based on subjective and objective parameters by grading them. Subjective a.Kandu(Itching) b. Ruja(Irritability) Objective a.Vivarnata (Erythema) b. Distribution of rash (W shape distribution of rash at genitocrural folds) c. Pidaka (papulo-vesicular rash) d. Srava (discharge) Timepoint: 14 days	—

Secondary

Measure	Time frame
To assesse the mode of action of Sariva malahara in Ahiputana in childrensTimepoint: 14 days	—

Countries

India

Contacts

Public ContactDr NARAYAN PAI B

Alvas Ayurveda medical college

ashwinitawarakhed@gmail.com7349162679

Outcome results